Quantum Computing recently shared its third-quarter financial results, and they surprised many by surpassing expectations. The company’s stock, QUBT, responded positively, rising after the announcement.
Reportedly, Quantum Computing achieved an adjusted profit of 1 cent per share for the quarter ending in September, bouncing back from a loss of 6 cents a year earlier. Revenue saw a staggering increase of 280%, reaching $384,000.
Before the earnings report, analysts had forecasted a loss of 6 cents, predicting revenue of only $100,000. During the earnings call, Quantum Computing noted that the revenue boost was mainly due to expanded research and development services and custom hardware contracts. They also started recognizing revenue from access to their Dirac-3 quantum optimization system via the cloud.
Looking ahead, analysts expect sales to hit $200,000 for the upcoming quarter.
In after-hours trading, Quantum Computing’s stock surged more than 7%, reaching 11.38. Prior to the earnings release, the stock had fallen by 42% in 2025 but experienced a more than 5% gain during regular trading on Friday.
The company operates a foundry in Tempe, Arizona, where they develop photonics-based quantum machines. Interim CEO Yuping Huang mentioned, “We ended the third quarter with $352 million in cash and $461 million in investments. We raised an additional $750 million after the quarter, providing us with a considerable liquidity position of over $1.5 billion for pursuing our long-term growth strategy.”
From a technical rating standpoint, quantum computing stocks, including Nvidia (NVDA), are being closely watched regarding the speed at which commercially viable quantum technology will emerge. Overall, quantum computing stocks hold a composite rating of 45 out of 99 per IBD’s assessment, where the best growth stocks score 90 or higher.
QUBT stock has an Accumulation/Distribution Rating of B-minus, which reflects changes in price and volume over the past 13 trading weeks. A rating of A+ indicates significant institutional buying, while E suggests heavy selling, with C being neutral.
Additionally, the stock’s Average True Range (ATR) stands at 9.60% over 21 days. This metric gauges the volatility of a stock’s price movements. Typically, stocks with high ATRs can trigger selling rules and lead to investor exits, while those with lower ATRs tend to reflect more gradual price changes.
IBD recommends focusing on stocks with ATRs up to 8%. Investors might want to be cautious with stocks exhibiting high ATR values.
